nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—TNF—urinary bladder cancer	0.497	1	CbGaD
Chloroquine—ABCB1—Mitomycin—urinary bladder cancer	0.0672	0.266	CbGbCtD
Chloroquine—CYP3A4—Thiotepa—urinary bladder cancer	0.0305	0.121	CbGbCtD
Chloroquine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0244	0.0969	CbGbCtD
Chloroquine—CYP3A5—Etoposide—urinary bladder cancer	0.0212	0.0841	CbGbCtD
Chloroquine—CYP2C8—Etoposide—urinary bladder cancer	0.0204	0.0809	CbGbCtD
Chloroquine—ABCB1—Gemcitabine—urinary bladder cancer	0.0193	0.0767	CbGbCtD
Chloroquine—ABCB1—Cisplatin—urinary bladder cancer	0.0141	0.0557	CbGbCtD
Chloroquine—ABCB1—Etoposide—urinary bladder cancer	0.0138	0.0547	CbGbCtD
Chloroquine—ABCB1—Doxorubicin—urinary bladder cancer	0.00942	0.0373	CbGbCtD
Chloroquine—ABCB1—Methotrexate—urinary bladder cancer	0.00913	0.0362	CbGbCtD
Chloroquine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00888	0.0352	CbGbCtD
Chloroquine—CYP3A4—Etoposide—urinary bladder cancer	0.00828	0.0328	CbGbCtD
Chloroquine—GSTA2—urine—urinary bladder cancer	0.00806	0.209	CbGeAlD
Chloroquine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00564	0.0224	CbGbCtD
Chloroquine—TNF—vagina—urinary bladder cancer	0.00329	0.0852	CbGeAlD
Chloroquine—GSTA2—prostate gland—urinary bladder cancer	0.00289	0.075	CbGeAlD
Chloroquine—TNF—lymph node—urinary bladder cancer	0.00213	0.0551	CbGeAlD
Chloroquine—GSTA2—epithelium—urinary bladder cancer	0.00213	0.0551	CbGeAlD
Chloroquine—CYP3A4—urine—urinary bladder cancer	0.00211	0.0547	CbGeAlD
Chloroquine—CYP2D6—urine—urinary bladder cancer	0.00208	0.0538	CbGeAlD
Chloroquine—GSTA2—renal system—urinary bladder cancer	0.00197	0.0511	CbGeAlD
Chloroquine—GSTA2—female reproductive system—urinary bladder cancer	0.00158	0.0409	CbGeAlD
Chloroquine—CYP3A5—prostate gland—urinary bladder cancer	0.00101	0.0262	CbGeAlD
Chloroquine—CYP2C8—renal system—urinary bladder cancer	0.000762	0.0197	CbGeAlD
Chloroquine—CYP1A1—epithelium—urinary bladder cancer	0.000758	0.0197	CbGeAlD
Chloroquine—CYP1A1—renal system—urinary bladder cancer	0.000703	0.0182	CbGeAlD
Chloroquine—CYP1A1—urethra—urinary bladder cancer	0.000691	0.0179	CbGeAlD
Chloroquine—CYP3A5—renal system—urinary bladder cancer	0.000688	0.0178	CbGeAlD
Chloroquine—CYP2C8—female reproductive system—urinary bladder cancer	0.00061	0.0158	CbGeAlD
Chloroquine—CYP1A1—female reproductive system—urinary bladder cancer	0.000563	0.0146	CbGeAlD
Chloroquine—CYP2C8—vagina—urinary bladder cancer	0.000552	0.0143	CbGeAlD
Chloroquine—Rash—Valrubicin—urinary bladder cancer	0.000537	0.00659	CcSEcCtD
Chloroquine—ABCB1—prostate gland—urinary bladder cancer	0.000536	0.0139	CbGeAlD
Chloroquine—Headache—Valrubicin—urinary bladder cancer	0.000534	0.00655	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.000522	0.0064	CcSEcCtD
Chloroquine—CYP3A4—renal system—urinary bladder cancer	0.000516	0.0134	CbGeAlD
Chloroquine—Decreased appetite—Mitomycin—urinary bladder cancer	0.00051	0.00626	CcSEcCtD
Chloroquine—CYP1A1—vagina—urinary bladder cancer	0.00051	0.0132	CbGeAlD
Chloroquine—CYP2D6—renal system—urinary bladder cancer	0.000508	0.0132	CbGeAlD
Chloroquine—Nausea—Valrubicin—urinary bladder cancer	0.000506	0.00621	CcSEcCtD
Chloroquine—Eruption—Doxorubicin—urinary bladder cancer	0.000501	0.00615	CcSEcCtD
Chloroquine—CYP3A5—vagina—urinary bladder cancer	0.000498	0.0129	CbGeAlD
Chloroquine—Pancytopenia—Thiotepa—urinary bladder cancer	0.000493	0.00605	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.000487	0.00597	CcSEcCtD
Chloroquine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000484	0.00593	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.000455	0.00558	CcSEcCtD
Chloroquine—ABCB1—seminal vesicle—urinary bladder cancer	0.000453	0.0118	CbGeAlD
Chloroquine—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.000446	0.00547	CcSEcCtD
Chloroquine—Scotoma—Epirubicin—urinary bladder cancer	0.000439	0.00538	CcSEcCtD
Chloroquine—Agranulocytosis—Thiotepa—urinary bladder cancer	0.000432	0.0053	CcSEcCtD
Chloroquine—Eosinophilia—Fluorouracil—urinary bladder cancer	0.000425	0.00522	CcSEcCtD
Chloroquine—Asthenia—Mitomycin—urinary bladder cancer	0.000421	0.00517	CcSEcCtD
Chloroquine—Pancytopenia—Gemcitabine—urinary bladder cancer	0.000415	0.00509	CcSEcCtD
Chloroquine—Hallucination—Thiotepa—urinary bladder cancer	0.000413	0.00507	CcSEcCtD
Chloroquine—CYP3A4—female reproductive system—urinary bladder cancer	0.000413	0.0107	CbGeAlD
Chloroquine—Neutropenia—Gemcitabine—urinary bladder cancer	0.000408	0.00501	CcSEcCtD
Chloroquine—Pancytopenia—Fluorouracil—urinary bladder cancer	0.000408	0.005	CcSEcCtD
Chloroquine—CYP2D6—female reproductive system—urinary bladder cancer	0.000407	0.0105	CbGeAlD
Chloroquine—Scotoma—Doxorubicin—urinary bladder cancer	0.000406	0.00498	CcSEcCtD
Chloroquine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000402	0.00493	CcSEcCtD
Chloroquine—ABCB1—epithelium—urinary bladder cancer	0.000394	0.0102	CbGeAlD
Chloroquine—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.000392	0.00481	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.000389	0.00477	CcSEcCtD
Chloroquine—Tinnitus—Thiotepa—urinary bladder cancer	0.000387	0.00475	CcSEcCtD
Chloroquine—Delirium—Epirubicin—urinary bladder cancer	0.000387	0.00475	CcSEcCtD
Chloroquine—Pancytopenia—Cisplatin—urinary bladder cancer	0.000387	0.00474	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.000386	0.00474	CcSEcCtD
Chloroquine—Vomiting—Mitomycin—urinary bladder cancer	0.000373	0.00458	CcSEcCtD
Chloroquine—Rash—Mitomycin—urinary bladder cancer	0.00037	0.00454	CcSEcCtD
Chloroquine—Headache—Mitomycin—urinary bladder cancer	0.000368	0.00451	CcSEcCtD
Chloroquine—Alopecia—Thiotepa—urinary bladder cancer	0.000367	0.0045	CcSEcCtD
Chloroquine—ABCB1—renal system—urinary bladder cancer	0.000365	0.00947	CbGeAlD
Chloroquine—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000363	0.00446	CcSEcCtD
Chloroquine—ABCB1—urethra—urinary bladder cancer	0.000359	0.0093	CbGeAlD
Chloroquine—Delirium—Doxorubicin—urinary bladder cancer	0.000358	0.0044	CcSEcCtD
Chloroquine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000357	0.00438	CcSEcCtD
Chloroquine—Dyskinesia—Epirubicin—urinary bladder cancer	0.000355	0.00435	CcSEcCtD
Chloroquine—Pancytopenia—Etoposide—urinary bladder cancer	0.000354	0.00434	CcSEcCtD
Chloroquine—Neutropenia—Etoposide—urinary bladder cancer	0.000349	0.00428	CcSEcCtD
Chloroquine—Nausea—Mitomycin—urinary bladder cancer	0.000349	0.00428	CcSEcCtD
Chloroquine—Vision blurred—Thiotepa—urinary bladder cancer	0.000341	0.00418	CcSEcCtD
Chloroquine—Skin exfoliation—Methotrexate—urinary bladder cancer	0.00034	0.00417	CcSEcCtD
Chloroquine—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.000334	0.0041	CcSEcCtD
Chloroquine—Agitation—Thiotepa—urinary bladder cancer	0.000332	0.00408	CcSEcCtD
Chloroquine—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000331	0.00405	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00033	0.00404	CcSEcCtD
Chloroquine—CYP1A1—lymph node—urinary bladder cancer	0.00033	0.00854	CbGeAlD
Chloroquine—Dyskinesia—Doxorubicin—urinary bladder cancer	0.000328	0.00402	CcSEcCtD
Chloroquine—Skin exfoliation—Epirubicin—urinary bladder cancer	0.000318	0.0039	CcSEcCtD
Chloroquine—Visual impairment—Cisplatin—urinary bladder cancer	0.000314	0.00385	CcSEcCtD
Chloroquine—Convulsion—Thiotepa—urinary bladder cancer	0.000313	0.00385	CcSEcCtD
Chloroquine—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.000313	0.00384	CcSEcCtD
Chloroquine—Agranulocytosis—Etoposide—urinary bladder cancer	0.00031	0.00381	CcSEcCtD
Chloroquine—Alopecia—Gemcitabine—urinary bladder cancer	0.000309	0.00379	CcSEcCtD
Chloroquine—Anxiety—Thiotepa—urinary bladder cancer	0.000307	0.00377	CcSEcCtD
Chloroquine—Tinnitus—Cisplatin—urinary bladder cancer	0.000304	0.00373	CcSEcCtD
Chloroquine—Alopecia—Fluorouracil—urinary bladder cancer	0.000304	0.00373	CcSEcCtD
Chloroquine—Confusional state—Thiotepa—urinary bladder cancer	0.000298	0.00365	CcSEcCtD
Chloroquine—Photosensitivity—Methotrexate—urinary bladder cancer	0.000294	0.00361	CcSEcCtD
Chloroquine—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.000294	0.00361	CcSEcCtD
Chloroquine—ABCB1—female reproductive system—urinary bladder cancer	0.000293	0.00758	CbGeAlD
Chloroquine—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000289	0.00355	CcSEcCtD
Chloroquine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000289	0.00355	CcSEcCtD
Chloroquine—Alopecia—Cisplatin—urinary bladder cancer	0.000288	0.00353	CcSEcCtD
Chloroquine—Erythema multiforme—Etoposide—urinary bladder cancer	0.000282	0.00346	CcSEcCtD
Chloroquine—Vision blurred—Fluorouracil—urinary bladder cancer	0.000282	0.00346	CcSEcCtD
Chloroquine—Anorexia—Thiotepa—urinary bladder cancer	0.000281	0.00345	CcSEcCtD
Chloroquine—Photosensitivity—Epirubicin—urinary bladder cancer	0.000275	0.00338	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000274	0.00336	CcSEcCtD
Chloroquine—Visual disturbance—Methotrexate—urinary bladder cancer	0.000273	0.00335	CcSEcCtD
Chloroquine—Vision blurred—Cisplatin—urinary bladder cancer	0.000267	0.00328	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000267	0.00328	CcSEcCtD
Chloroquine—ABCB1—vagina—urinary bladder cancer	0.000265	0.00686	CbGeAlD
Chloroquine—Alopecia—Etoposide—urinary bladder cancer	0.000264	0.00324	CcSEcCtD
Chloroquine—Convulsion—Fluorouracil—urinary bladder cancer	0.000259	0.00318	CcSEcCtD
Chloroquine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000257	0.00315	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000256	0.00314	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000255	0.00313	CcSEcCtD
Chloroquine—Photosensitivity—Doxorubicin—urinary bladder cancer	0.000255	0.00313	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00025	0.00307	CcSEcCtD
Chloroquine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000248	0.00305	CcSEcCtD
Chloroquine—Confusional state—Fluorouracil—urinary bladder cancer	0.000246	0.00302	CcSEcCtD
Chloroquine—Convulsion—Cisplatin—urinary bladder cancer	0.000246	0.00301	CcSEcCtD
Chloroquine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000244	0.003	CcSEcCtD
Chloroquine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000243	0.00298	CcSEcCtD
Chloroquine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000243	0.00298	CcSEcCtD
Chloroquine—Anxiety—Cisplatin—urinary bladder cancer	0.000241	0.00295	CcSEcCtD
Chloroquine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000239	0.00293	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000237	0.00291	CcSEcCtD
Chloroquine—Anorexia—Gemcitabine—urinary bladder cancer	0.000237	0.0029	CcSEcCtD
Chloroquine—Urticaria—Thiotepa—urinary bladder cancer	0.000235	0.00288	CcSEcCtD
Chloroquine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000233	0.00286	CcSEcCtD
Chloroquine—Anorexia—Fluorouracil—urinary bladder cancer	0.000233	0.00286	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000233	0.00286	CcSEcCtD
Chloroquine—Hypotension—Gemcitabine—urinary bladder cancer	0.000232	0.00285	CcSEcCtD
Chloroquine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000231	0.00284	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000231	0.00284	CcSEcCtD
Chloroquine—Hypotension—Fluorouracil—urinary bladder cancer	0.000228	0.0028	CcSEcCtD
Chloroquine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000227	0.00278	CcSEcCtD
Chloroquine—Convulsion—Etoposide—urinary bladder cancer	0.000225	0.00276	CcSEcCtD
Chloroquine—Insomnia—Gemcitabine—urinary bladder cancer	0.000225	0.00276	CcSEcCtD
Chloroquine—Eosinophilia—Methotrexate—urinary bladder cancer	0.000221	0.00271	CcSEcCtD
Chloroquine—Insomnia—Fluorouracil—urinary bladder cancer	0.000221	0.00271	CcSEcCtD
Chloroquine—Anorexia—Cisplatin—urinary bladder cancer	0.000221	0.00271	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000218	0.00267	CcSEcCtD
Chloroquine—Hypotension—Cisplatin—urinary bladder cancer	0.000216	0.00265	CcSEcCtD
Chloroquine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000216	0.00265	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000214	0.00263	CcSEcCtD
Chloroquine—Confusional state—Etoposide—urinary bladder cancer	0.000214	0.00262	CcSEcCtD
Chloroquine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000212	0.0026	CcSEcCtD
Chloroquine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000212	0.0026	CcSEcCtD
Chloroquine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000212	0.0026	CcSEcCtD
Chloroquine—Asthenia—Thiotepa—urinary bladder cancer	0.000212	0.0026	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000211	0.00259	CcSEcCtD
Chloroquine—Neutropenia—Methotrexate—urinary bladder cancer	0.000209	0.00256	CcSEcCtD
Chloroquine—Pruritus—Thiotepa—urinary bladder cancer	0.000209	0.00256	CcSEcCtD
Chloroquine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000208	0.00255	CcSEcCtD
Chloroquine—Eosinophilia—Epirubicin—urinary bladder cancer	0.000207	0.00254	CcSEcCtD
Chloroquine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000205	0.00251	CcSEcCtD
Chloroquine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000204	0.0025	CcSEcCtD
Chloroquine—Anorexia—Etoposide—urinary bladder cancer	0.000202	0.00248	CcSEcCtD
Chloroquine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000202	0.00248	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000202	0.00247	CcSEcCtD
Chloroquine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000201	0.00247	CcSEcCtD
Chloroquine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000201	0.00247	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.0002	0.00245	CcSEcCtD
Chloroquine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000199	0.00244	CcSEcCtD
Chloroquine—Hypotension—Etoposide—urinary bladder cancer	0.000198	0.00243	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000197	0.00242	CcSEcCtD
Chloroquine—Neutropenia—Epirubicin—urinary bladder cancer	0.000195	0.0024	CcSEcCtD
Chloroquine—Urticaria—Fluorouracil—urinary bladder cancer	0.000194	0.00238	CcSEcCtD
Chloroquine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000192	0.00235	CcSEcCtD
Chloroquine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000191	0.00234	CcSEcCtD
Chloroquine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000191	0.00234	CcSEcCtD
Chloroquine—Vomiting—Thiotepa—urinary bladder cancer	0.000188	0.0023	CcSEcCtD
Chloroquine—Rash—Thiotepa—urinary bladder cancer	0.000186	0.00228	CcSEcCtD
Chloroquine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000186	0.00228	CcSEcCtD
Chloroquine—Headache—Thiotepa—urinary bladder cancer	0.000185	0.00227	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000185	0.00227	CcSEcCtD
Chloroquine—Decreased appetite—Etoposide—urinary bladder cancer	0.000184	0.00226	CcSEcCtD
Chloroquine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000184	0.00225	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000183	0.00225	CcSEcCtD
Chloroquine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000181	0.00222	CcSEcCtD
Chloroquine—Hepatitis—Methotrexate—urinary bladder cancer	0.000179	0.00219	CcSEcCtD
Chloroquine—Asthenia—Gemcitabine—urinary bladder cancer	0.000178	0.00219	CcSEcCtD
Chloroquine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000177	0.00217	CcSEcCtD
Chloroquine—Pruritus—Gemcitabine—urinary bladder cancer	0.000176	0.00216	CcSEcCtD
Chloroquine—Nausea—Thiotepa—urinary bladder cancer	0.000175	0.00215	CcSEcCtD
Chloroquine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000175	0.00214	CcSEcCtD
Chloroquine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000174	0.00213	CcSEcCtD
Chloroquine—Pruritus—Fluorouracil—urinary bladder cancer	0.000173	0.00212	CcSEcCtD
Chloroquine—Visual impairment—Methotrexate—urinary bladder cancer	0.000172	0.00211	CcSEcCtD
Chloroquine—ABCB1—lymph node—urinary bladder cancer	0.000171	0.00444	CbGeAlD
Chloroquine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000171	0.0021	CcSEcCtD
Chloroquine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00017	0.00208	CcSEcCtD
Chloroquine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000169	0.00207	CcSEcCtD
Chloroquine—Urticaria—Etoposide—urinary bladder cancer	0.000168	0.00207	CcSEcCtD
Chloroquine—Abdominal pain—Etoposide—urinary bladder cancer	0.000168	0.00206	CcSEcCtD
Chloroquine—Hepatitis—Epirubicin—urinary bladder cancer	0.000167	0.00205	CcSEcCtD
Chloroquine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000167	0.00205	CcSEcCtD
Chloroquine—Tinnitus—Methotrexate—urinary bladder cancer	0.000167	0.00205	CcSEcCtD
Chloroquine—Asthenia—Cisplatin—urinary bladder cancer	0.000166	0.00204	CcSEcCtD
Chloroquine—Visual impairment—Epirubicin—urinary bladder cancer	0.000161	0.00198	CcSEcCtD
Chloroquine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000161	0.00197	CcSEcCtD
Chloroquine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000158	0.00194	CcSEcCtD
Chloroquine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000158	0.00194	CcSEcCtD
Chloroquine—Alopecia—Methotrexate—urinary bladder cancer	0.000158	0.00194	CcSEcCtD
Chloroquine—Vomiting—Gemcitabine—urinary bladder cancer	0.000158	0.00194	CcSEcCtD
Chloroquine—Rash—Gemcitabine—urinary bladder cancer	0.000157	0.00192	CcSEcCtD
Chloroquine—Tinnitus—Epirubicin—urinary bladder cancer	0.000156	0.00191	CcSEcCtD
Chloroquine—Headache—Gemcitabine—urinary bladder cancer	0.000156	0.00191	CcSEcCtD
Chloroquine—Vomiting—Fluorouracil—urinary bladder cancer	0.000155	0.0019	CcSEcCtD
Chloroquine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000155	0.0019	CcSEcCtD
Chloroquine—Rash—Fluorouracil—urinary bladder cancer	0.000154	0.00189	CcSEcCtD
Chloroquine—Headache—Fluorouracil—urinary bladder cancer	0.000153	0.00188	CcSEcCtD
Chloroquine—Asthenia—Etoposide—urinary bladder cancer	0.000152	0.00187	CcSEcCtD
Chloroquine—Pruritus—Etoposide—urinary bladder cancer	0.00015	0.00184	CcSEcCtD
Chloroquine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000149	0.00183	CcSEcCtD
Chloroquine—Alopecia—Epirubicin—urinary bladder cancer	0.000148	0.00181	CcSEcCtD
Chloroquine—Nausea—Gemcitabine—urinary bladder cancer	0.000148	0.00181	CcSEcCtD
Chloroquine—Vomiting—Cisplatin—urinary bladder cancer	0.000147	0.00181	CcSEcCtD
Chloroquine—Vision blurred—Methotrexate—urinary bladder cancer	0.000147	0.0018	CcSEcCtD
Chloroquine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000146	0.0018	CcSEcCtD
Chloroquine—Rash—Cisplatin—urinary bladder cancer	0.000146	0.00179	CcSEcCtD
Chloroquine—Diarrhoea—Etoposide—urinary bladder cancer	0.000145	0.00178	CcSEcCtD
Chloroquine—Nausea—Fluorouracil—urinary bladder cancer	0.000145	0.00178	CcSEcCtD
Chloroquine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000144	0.00177	CcSEcCtD
Chloroquine—Nausea—Cisplatin—urinary bladder cancer	0.000138	0.00169	CcSEcCtD
Chloroquine—Vision blurred—Epirubicin—urinary bladder cancer	0.000137	0.00168	CcSEcCtD
Chloroquine—Alopecia—Doxorubicin—urinary bladder cancer	0.000137	0.00168	CcSEcCtD
Chloroquine—Convulsion—Methotrexate—urinary bladder cancer	0.000135	0.00165	CcSEcCtD
Chloroquine—Vomiting—Etoposide—urinary bladder cancer	0.000135	0.00165	CcSEcCtD
Chloroquine—Agitation—Epirubicin—urinary bladder cancer	0.000134	0.00164	CcSEcCtD
Chloroquine—Rash—Etoposide—urinary bladder cancer	0.000134	0.00164	CcSEcCtD
Chloroquine—Headache—Etoposide—urinary bladder cancer	0.000133	0.00163	CcSEcCtD
Chloroquine—Confusional state—Methotrexate—urinary bladder cancer	0.000128	0.00157	CcSEcCtD
Chloroquine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000127	0.00156	CcSEcCtD
Chloroquine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000127	0.00156	CcSEcCtD
Chloroquine—Convulsion—Epirubicin—urinary bladder cancer	0.000126	0.00155	CcSEcCtD
Chloroquine—Nausea—Etoposide—urinary bladder cancer	0.000126	0.00155	CcSEcCtD
Chloroquine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000124	0.00153	CcSEcCtD
Chloroquine—Agitation—Doxorubicin—urinary bladder cancer	0.000124	0.00152	CcSEcCtD
Chloroquine—Anxiety—Epirubicin—urinary bladder cancer	0.000124	0.00152	CcSEcCtD
Chloroquine—Anorexia—Methotrexate—urinary bladder cancer	0.000121	0.00149	CcSEcCtD
Chloroquine—Confusional state—Epirubicin—urinary bladder cancer	0.00012	0.00147	CcSEcCtD
Chloroquine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000119	0.00146	CcSEcCtD
Chloroquine—Hypotension—Methotrexate—urinary bladder cancer	0.000119	0.00146	CcSEcCtD
Chloroquine—Convulsion—Doxorubicin—urinary bladder cancer	0.000117	0.00143	CcSEcCtD
Chloroquine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000116	0.00143	CcSEcCtD
Chloroquine—Insomnia—Methotrexate—urinary bladder cancer	0.000115	0.00141	CcSEcCtD
Chloroquine—Anxiety—Doxorubicin—urinary bladder cancer	0.000114	0.0014	CcSEcCtD
Chloroquine—Anorexia—Epirubicin—urinary bladder cancer	0.000113	0.00139	CcSEcCtD
Chloroquine—Hypotension—Epirubicin—urinary bladder cancer	0.000111	0.00136	CcSEcCtD
Chloroquine—Confusional state—Doxorubicin—urinary bladder cancer	0.000111	0.00136	CcSEcCtD
Chloroquine—Decreased appetite—Methotrexate—urinary bladder cancer	0.00011	0.00135	CcSEcCtD
Chloroquine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00011	0.00135	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00011	0.00135	CcSEcCtD
Chloroquine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000108	0.00132	CcSEcCtD
Chloroquine—Insomnia—Epirubicin—urinary bladder cancer	0.000108	0.00132	CcSEcCtD
Chloroquine—Anorexia—Doxorubicin—urinary bladder cancer	0.000105	0.00129	CcSEcCtD
Chloroquine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000105	0.00128	CcSEcCtD
Chloroquine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000103	0.00127	CcSEcCtD
Chloroquine—Hypotension—Doxorubicin—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Chloroquine—Urticaria—Methotrexate—urinary bladder cancer	0.000101	0.00124	CcSEcCtD
Chloroquine—Abdominal pain—Methotrexate—urinary bladder cancer	0.0001	0.00123	CcSEcCtD
Chloroquine—Insomnia—Doxorubicin—urinary bladder cancer	9.95e-05	0.00122	CcSEcCtD
Chloroquine—Feeling abnormal—Epirubicin—urinary bladder cancer	9.8e-05	0.0012	CcSEcCtD
Chloroquine—Decreased appetite—Doxorubicin—urinary bladder cancer	9.56e-05	0.00117	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	9.5e-05	0.00116	CcSEcCtD
Chloroquine—Urticaria—Epirubicin—urinary bladder cancer	9.44e-05	0.00116	CcSEcCtD
Chloroquine—Abdominal pain—Epirubicin—urinary bladder cancer	9.4e-05	0.00115	CcSEcCtD
Chloroquine—Asthenia—Methotrexate—urinary bladder cancer	9.11e-05	0.00112	CcSEcCtD
Chloroquine—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.06e-05	0.00111	CcSEcCtD
Chloroquine—Pruritus—Methotrexate—urinary bladder cancer	8.99e-05	0.0011	CcSEcCtD
Chloroquine—Urticaria—Doxorubicin—urinary bladder cancer	8.74e-05	0.00107	CcSEcCtD
Chloroquine—Abdominal pain—Doxorubicin—urinary bladder cancer	8.7e-05	0.00107	CcSEcCtD
Chloroquine—Diarrhoea—Methotrexate—urinary bladder cancer	8.69e-05	0.00107	CcSEcCtD
Chloroquine—Asthenia—Epirubicin—urinary bladder cancer	8.53e-05	0.00105	CcSEcCtD
Chloroquine—Pruritus—Epirubicin—urinary bladder cancer	8.41e-05	0.00103	CcSEcCtD
Chloroquine—Diarrhoea—Epirubicin—urinary bladder cancer	8.13e-05	0.000998	CcSEcCtD
Chloroquine—Vomiting—Methotrexate—urinary bladder cancer	8.08e-05	0.000991	CcSEcCtD
Chloroquine—Rash—Methotrexate—urinary bladder cancer	8.01e-05	0.000983	CcSEcCtD
Chloroquine—Headache—Methotrexate—urinary bladder cancer	7.96e-05	0.000976	CcSEcCtD
Chloroquine—Asthenia—Doxorubicin—urinary bladder cancer	7.89e-05	0.000968	CcSEcCtD
Chloroquine—Pruritus—Doxorubicin—urinary bladder cancer	7.78e-05	0.000955	CcSEcCtD
Chloroquine—Vomiting—Epirubicin—urinary bladder cancer	7.56e-05	0.000927	CcSEcCtD
Chloroquine—Nausea—Methotrexate—urinary bladder cancer	7.55e-05	0.000926	CcSEcCtD
Chloroquine—Diarrhoea—Doxorubicin—urinary bladder cancer	7.53e-05	0.000923	CcSEcCtD
Chloroquine—Rash—Epirubicin—urinary bladder cancer	7.5e-05	0.00092	CcSEcCtD
Chloroquine—Headache—Epirubicin—urinary bladder cancer	7.45e-05	0.000914	CcSEcCtD
Chloroquine—Nausea—Epirubicin—urinary bladder cancer	7.06e-05	0.000866	CcSEcCtD
Chloroquine—Vomiting—Doxorubicin—urinary bladder cancer	6.99e-05	0.000858	CcSEcCtD
Chloroquine—Rash—Doxorubicin—urinary bladder cancer	6.94e-05	0.000851	CcSEcCtD
Chloroquine—Headache—Doxorubicin—urinary bladder cancer	6.89e-05	0.000845	CcSEcCtD
Chloroquine—Nausea—Doxorubicin—urinary bladder cancer	6.53e-05	0.000802	CcSEcCtD
Chloroquine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	3.81e-05	0.000291	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	3.8e-05	0.00029	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TP53—urinary bladder cancer	3.79e-05	0.000289	CbGpPWpGaD
Chloroquine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	3.78e-05	0.000289	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	3.75e-05	0.000287	CbGpPWpGaD
Chloroquine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	3.74e-05	0.000286	CbGpPWpGaD
Chloroquine—TLR9—Immune System—ERBB2—urinary bladder cancer	3.64e-05	0.000278	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.62e-05	0.000277	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—MTHFR—urinary bladder cancer	3.61e-05	0.000276	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.6e-05	0.000276	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	3.6e-05	0.000275	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—NAT1—urinary bladder cancer	3.6e-05	0.000275	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TERT—urinary bladder cancer	3.59e-05	0.000275	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—TP53—urinary bladder cancer	3.55e-05	0.000271	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.54e-05	0.000271	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—CDK4—urinary bladder cancer	3.52e-05	0.000269	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	3.49e-05	0.000267	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	3.48e-05	0.000266	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—HRAS—urinary bladder cancer	3.47e-05	0.000266	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.32e-05	0.000254	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.3e-05	0.000252	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—NAT1—urinary bladder cancer	3.3e-05	0.000252	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	3.3e-05	0.000252	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—FGFR3—urinary bladder cancer	3.3e-05	0.000252	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL2—urinary bladder cancer	3.29e-05	0.000252	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	3.29e-05	0.000252	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.29e-05	0.000251	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.25e-05	0.000248	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.23e-05	0.000247	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.2e-05	0.000245	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—ESR1—urinary bladder cancer	3.2e-05	0.000245	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—PPARG—urinary bladder cancer	3.2e-05	0.000245	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	3.14e-05	0.00024	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CDKN1A—urinary bladder cancer	3.11e-05	0.000238	CbGpPWpGaD
Chloroquine—TLR9—Immune System—PTEN—urinary bladder cancer	3.1e-05	0.000237	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—CREBBP—urinary bladder cancer	3.07e-05	0.000235	CbGpPWpGaD
Chloroquine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.05e-05	0.000233	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.03e-05	0.000232	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	3.02e-05	0.000231	CbGpPWpGaD
Chloroquine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.01e-05	0.00023	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	2.97e-05	0.000227	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	2.96e-05	0.000227	CbGpPWpGaD
Chloroquine—TLR9—Immune System—EP300—urinary bladder cancer	2.96e-05	0.000226	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PPARG—urinary bladder cancer	2.93e-05	0.000224	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	2.89e-05	0.000221	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	2.88e-05	0.00022	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	2.88e-05	0.00022	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—NAT1—urinary bladder cancer	2.88e-05	0.00022	CbGpPWpGaD
Chloroquine—TLR9—Immune System—SRC—urinary bladder cancer	2.87e-05	0.00022	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	2.86e-05	0.000219	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	2.85e-05	0.000218	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—CREBBP—urinary bladder cancer	2.81e-05	0.000215	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CREBBP—urinary bladder cancer	2.81e-05	0.000215	CbGpPWpGaD
Chloroquine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.8e-05	0.000214	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	2.8e-05	0.000214	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—RHOA—urinary bladder cancer	2.78e-05	0.000213	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IGF1—urinary bladder cancer	2.77e-05	0.000212	CbGpPWpGaD
Chloroquine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.77e-05	0.000211	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	2.73e-05	0.000209	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	2.72e-05	0.000208	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	2.71e-05	0.000207	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	2.71e-05	0.000207	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.63e-05	0.000201	CbGpPWpGaD
Chloroquine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	2.58e-05	0.000197	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—ERBB2—urinary bladder cancer	2.57e-05	0.000197	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	2.57e-05	0.000196	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—RHOA—urinary bladder cancer	2.54e-05	0.000194	CbGpPWpGaD
Chloroquine—TLR9—Immune System—EGFR—urinary bladder cancer	2.52e-05	0.000193	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	2.5e-05	0.000191	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	2.48e-05	0.00019	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.44e-05	0.000187	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.41e-05	0.000185	CbGpPWpGaD
Chloroquine—TLR9—Immune System—KRAS—urinary bladder cancer	2.38e-05	0.000182	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.37e-05	0.000181	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.36e-05	0.00018	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—ERBB2—urinary bladder cancer	2.35e-05	0.00018	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	2.31e-05	0.000177	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PTGS2—urinary bladder cancer	2.3e-05	0.000176	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.24e-05	0.000171	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	2.23e-05	0.000171	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCL8—urinary bladder cancer	2.23e-05	0.00017	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—MMP9—urinary bladder cancer	2.21e-05	0.000169	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.19e-05	0.000167	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—TYMP—urinary bladder cancer	2.18e-05	0.000167	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.18e-05	0.000167	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.13e-05	0.000163	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL2—urinary bladder cancer	2.13e-05	0.000163	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	2.11e-05	0.000161	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.1e-05	0.00016	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—EP300—urinary bladder cancer	2.09e-05	0.00016	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.09e-05	0.00016	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCND1—urinary bladder cancer	2.08e-05	0.000159	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.06e-05	0.000158	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.06e-05	0.000157	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	2.05e-05	0.000157	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—SRC—urinary bladder cancer	2.04e-05	0.000156	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HRAS—urinary bladder cancer	2.02e-05	0.000155	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MMP9—urinary bladder cancer	2.02e-05	0.000154	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CDKN1A—urinary bladder cancer	2.01e-05	0.000154	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PTEN—urinary bladder cancer	2.01e-05	0.000154	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.01e-05	0.000153	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PTEN—urinary bladder cancer	2e-05	0.000153	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	2e-05	0.000153	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—NAT2—urinary bladder cancer	1.97e-05	0.000151	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.96e-05	0.00015	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.92e-05	0.000147	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—EP300—urinary bladder cancer	1.92e-05	0.000146	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—EP300—urinary bladder cancer	1.91e-05	0.000146	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.91e-05	0.000146	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.87e-05	0.000143	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SRC—urinary bladder cancer	1.86e-05	0.000142	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.81e-05	0.000138	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.8e-05	0.000138	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—EGFR—urinary bladder cancer	1.78e-05	0.000136	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.77e-05	0.000136	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.77e-05	0.000136	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.74e-05	0.000133	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.71e-05	0.000131	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—RRM2—urinary bladder cancer	1.7e-05	0.00013	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—KRAS—urinary bladder cancer	1.69e-05	0.000129	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.67e-05	0.000128	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.67e-05	0.000128	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.67e-05	0.000128	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MYC—urinary bladder cancer	1.67e-05	0.000127	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.64e-05	0.000126	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—EGFR—urinary bladder cancer	1.63e-05	0.000125	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.62e-05	0.000124	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.62e-05	0.000124	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.59e-05	0.000122	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.58e-05	0.000121	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	1.58e-05	0.000121	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—ENO2—urinary bladder cancer	1.58e-05	0.000121	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.58e-05	0.000121	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.57e-05	0.00012	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.56e-05	0.000119	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—KRAS—urinary bladder cancer	1.54e-05	0.000118	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.53e-05	0.000117	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.51e-05	0.000115	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.48e-05	0.000114	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.46e-05	0.000112	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.45e-05	0.000111	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.45e-05	0.000111	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.44e-05	0.00011	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—HRAS—urinary bladder cancer	1.43e-05	0.00011	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.4e-05	0.000107	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.4e-05	0.000107	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.38e-05	0.000106	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.38e-05	0.000105	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TP53—urinary bladder cancer	1.37e-05	0.000105	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.36e-05	0.000104	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.35e-05	0.000103	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.34e-05	0.000103	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—HRAS—urinary bladder cancer	1.31e-05	0.0001	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.28e-05	9.8e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.27e-05	9.72e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.26e-05	9.63e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.26e-05	9.63e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.23e-05	9.43e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	9.34e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.19e-05	9.08e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.19e-05	9.08e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.17e-05	8.91e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.15e-05	8.8e-05	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.14e-05	8.75e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.13e-05	8.65e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	8.58e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.08e-05	8.23e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.07e-05	8.21e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.06e-05	8.11e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.04e-05	7.98e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.03e-05	7.89e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	7.89e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.03e-05	7.85e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.02e-05	7.77e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	9.88e-06	7.55e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.86e-06	7.54e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	9.86e-06	7.54e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	9.74e-06	7.45e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	9.74e-06	7.45e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	9.72e-06	7.43e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	9.71e-06	7.42e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	9.7e-06	7.42e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	9.57e-06	7.32e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.41e-06	7.19e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	9.33e-06	7.14e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	9.16e-06	7.01e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	9.12e-06	6.97e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	9.04e-06	6.91e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	8.93e-06	6.83e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	8.93e-06	6.83e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	8.61e-06	6.59e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	8.55e-06	6.54e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.47e-06	6.48e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	8.4e-06	6.42e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.38e-06	6.41e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	7.98e-06	6.1e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	7.9e-06	6.04e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—TYMS—urinary bladder cancer	7.87e-06	6.02e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	7.78e-06	5.95e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	7.78e-06	5.95e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.76e-06	5.94e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.76e-06	5.94e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.53e-06	5.76e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.45e-06	5.7e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	7.42e-06	5.67e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	7.39e-06	5.65e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	7.33e-06	5.61e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	7.33e-06	5.61e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.32e-06	5.6e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	7.1e-06	5.43e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	7.02e-06	5.37e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	6.98e-06	5.34e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.9e-06	5.27e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.88e-06	5.26e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	6.71e-06	5.13e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	6.48e-06	4.96e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	6.4e-06	4.9e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.26e-06	4.78e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	6.15e-06	4.7e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.81e-06	4.45e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.58e-06	4.27e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	5.49e-06	4.2e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.36e-06	4.1e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.26e-06	4.02e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.22e-06	3.99e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	5.07e-06	3.88e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.05e-06	3.86e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	5.04e-06	3.85e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.85e-06	3.71e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.84e-06	3.7e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.79e-06	3.67e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.79e-06	3.67e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	4.79e-06	3.66e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.59e-06	3.51e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—EP300—urinary bladder cancer	4.57e-06	3.49e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.51e-06	3.45e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.39e-06	3.36e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.39e-06	3.36e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.24e-06	3.24e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.19e-06	3.2e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.13e-06	3.16e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.83e-06	2.93e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—EP300—urinary bladder cancer	3.65e-06	2.79e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.61e-06	2.76e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.44e-06	2.63e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.44e-06	2.63e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.3e-06	2.52e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.7e-06	2.07e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.36e-06	1.8e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.25e-06	1.72e-05	CbGpPWpGaD
